These findings revealed that several biomarkers, particularly fibronectin, pAkt, pErk, pStat3, pAMPK, HMGA1, and IGF2BP1, exhibited significant differences in expression based on the pAXL status in patients with GC. The gene discussed is HMGA1; the disease is gastric cancer.